Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • Diabetes and Endocrinology
  • Diabetes and Endocrinology News
  • Long-Acting GLP-1RAs...

Long-Acting GLP-1RAs Lower Cardiovascular, Kidney Risks and Mortality in Type 2 Diabetes, Meta-Analysis Finds

Written By : Medha Baranwal |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2025-04-08T08:00:38+05:30  |  Updated On 8 April 2025 12:06 PM IST
Long-Acting GLP-1RAs Lower Cardiovascular, Kidney Risks and Mortality in Type 2 Diabetes, Meta-Analysis Finds
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

UK: A systematic review and meta-analysis of randomized trials have highlighted the significant benefits of long-acting glucagon-like peptide-1 receptor agonists (GLP-1RAs), both injectable and oral, in individuals with type 2 diabetes (T2D). The findings were published online in Diabetes Care.

Analyzing data from 71,351 patients, Matthew M.Y. Lee, School of Cardiovascular & Metabolic Health, University of Glasgow, Glasgow, U.K., and colleagues found that these medications reduced major adverse cardiovascular events (MACE) and hospitalization for heart failure by 14%, lowered kidney-related complications by 17%, and decreased all-cause mortality by 12%. Importantly, these improvements were achieved without an increased risk of severe hypoglycemia, retinopathy, or pancreatic disorders, reinforcing the potential of GLP-1RAs as a valuable therapeutic option for individuals with T2D at risk of cardiovascular and renal complications.

Glucagon-like peptide-1 receptor agonists are known to reduce MACE in type 2 diabetes, but the extent of benefits across both subcutaneous and oral formulations remains uncertain. A meta-analysis incorporating data from the Semaglutide Cardiovascular Outcomes Trial (SOUL) and the Evaluate Renal Function with Semaglutide Once Weekly (FLOW) trial was conducted to evaluate cardiovascular and kidney-related outcomes. Long-acting GLP-1RAs, defined by their ability to provide 24-hour pharmacological activity, were assessed through a systematic review of PubMed up to 7 February 2025. Randomized placebo-controlled trials with at least 500 participants were included.

A random-effects model estimated hazard ratios for MACE, its components, all-cause mortality, hospitalization for heart failure, and kidney outcomes, including kidney failure, significant eGFR decline, and kidney-related death. Additionally, worsening kidney function and safety outcomes were analyzed to determine the risks and benefits of long-acting GLP-1RAs in T2D management.

Key Findings:

  • Analysis of 10 trials involving 71,351 participants showed that long-acting GLP-1RAs reduced the incidence of major adverse cardiovascular events (MACE) by 14% (HR 0.86).
  • Hospitalization for heart failure (HHF) decreased by 14% (HR 0.86).
  • The composite kidney outcome, including kidney failure, significant eGFR decline, or kidney-related death, was reduced by 17% (HR 0.83).
  • All-cause mortality declined by 12% (HR 0.88).
  • There was a consistent 14% reduction across all MACE components.
  • There were no significant differences between subcutaneous and oral GLP-1RA administration routes.
  • There was no increased risk of severe hypoglycemia, retinopathy, or pancreatic events.

While long-acting glucagon-like peptide-1 receptor agonists (GLP-1RAs), including both injectable and oral formulations, have shown significant reductions in major adverse cardiovascular events, hospitalization for heart failure, kidney complications, and all-cause mortality in individuals with type 2 diabetes, researchers highlight certain limitations. They noted that "trial-level meta-analyses restrict detailed subgroup analyses and may introduce ecological bias, potentially affecting the precision of findings across diverse patient populations."

Despite these limitations, they concluded that "the overall evidence supports the cardiovascular and renal benefits of long-acting GLP-1RAs, reinforcing their role as an effective therapeutic option in T2D management."

Reference:

Matthew M.Y. Lee, Naveed Sattar, Rodica Pop-Busui, John Deanfield, Scott S. Emerson, Silvio E. Inzucchi, Johannes F.E. Mann, Nikolaus Marx, Sharon L. Mulvagh, Neil R. Poulter, Sunil V. Badve, Richard E. Pratley, Vlado Perkovic, John B. Buse, Darren K. McGuire, SOUL Trial Investigators; Cardiovascular and Kidney Outcomes and Mortality With Long-Acting Injectable and Oral Glucagon-Like Peptide 1 Receptor Agonists in Individuals With Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Trials. Diabetes Care 2025; dc250241. https://doi.org/10.2337/dc25-0241


Diabetes CareGlucagon-like peptide 1 receptor agonists (GLP-1RA)major adverse cardiovascular events (MACE)type 2 diabetes (T2D)
Source : Diabetes Care
Medha Baranwal
Medha Baranwal

    MSc. Biotechnology

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story

    Editorial

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    Azmarda Outperforms Generic Sacubitril/Valsartan in HFrEF Management, says new study

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Re-visiting the Role of Pneumococcal Vaccination in Patients with Cardiovascular Diseases

    Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

    Prediabetes and the Mind: Unraveling Cognitive and Mental Health Risks

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Journal Club Today

    Universal Heart Health Advice Ignores Realities in Low-Income Countries: Study Finds

    Universal Heart Health Advice Ignores Realities in Low-Income Countries: Study Finds

    View All

    Health News Today

    Health Bulletin 24/May/2025

    Health Bulletin 24/May/2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok